Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

0

Share

Download to read offline

HELLP syndrome

Download to read offline

PREGNANCY RELATED PREECLAMPSIA ASSICIATED CRITICAL CONDITION

Related Books

Free with a 30 day trial from Scribd

See all

Related Audiobooks

Free with a 30 day trial from Scribd

See all
  • Be the first to like this

HELLP syndrome

  1. 1. HELLP Syndrome as a separate entity Dr. Mohammed Abdalla EGYPT, Domiat G. Hospital
  2. 2. HELLP Syndrome may it be a separate entity? yes
  3. 3. HELLP, a syndrome characterized by hemolysis, elevated liver enzyme levels and a low platelet count, is an obstetric complication that is frequently misdiagnosed at initial presentation. Many investigators consider the syndrome to be a variant of preeclampsia, but it may be a separate entity.
  4. 4. In some cases , HELLP symptoms are the first warning of preeclampsia and the condition is misdiagnosed as hepatitis, idiopathic thrombocytopenic purpura, gallbladder disease, or thrombotic thrombocytopenic purpura.
  5. 5. Epidemiology and Risk Factors  HELLP syndrome 0.2 to 0.6 % of all pregnancies.  Preeclampsia 5 to 7 % of all pregnancies. Superimposed HELLP syndrome develops in 4 to 12 percent of women with preeclampsia or eclampsia. Wolf JL. Liver disease in pregnancy. Med Clin North Am 1996. Maternal mortality has been estimated to be as high as 2- 24% Perinatal mortality is equally high, ranging from 9 –39 %.
  6. 6.  The hemolysis in HELLP syndrome is a microangiopathic hemolytic anemia. Red blood cells become fragmented as they pass through small blood vessels with endothelial damage and fibrin deposits.  The peripheral smear may reveal spherocytes, schistocytes, triangular cells and burr cells.  increase in Bilirubin and lactic dehydrogenase levels. Etiology and Pathogenesis
  7. 7.  The elevated liver enzyme levels in the syndrome are thought to be secondary to obstruction of hepatic blood flow by fibrin deposits in the sinusoids. This obstruction leads to periportal necrosis and, in severe cases, intrahepatic hemorrhage, subcapsular hematoma formation or hepatic rupture. Etiology and Pathogenesis
  8. 8.  The thrombocytopenia has been attributed to increased consumption and/or destruction of platelets. With platelet activation, thromboxane A and serotonin are released, causing vasospasm, platelet agglutination and aggregation, and further endothelial damage. Etiology and Pathogenesis
  9. 9. Clinical Presentation  90%of patients present with generalized malaise,  65 % with epigastric pain,  30 % with nausea and vomiting,  31 percent with headache. All are nonspecific symptoms
  10. 10. Because of the variable nature of the clinical presentation, the diagnosis of HELLP syndrome is generally delayed for an average of eight days. Usually presented by complications
  11. 11. In one retrospective chart review of patients with HELLP syndrome, only two of 14 patients entered the hospital with the correct diagnosis.
  12. 12. Because early diagnosis of this syndrome is critical, any pregnant woman who presents with malaise or a viral-type illness in the third trimester should be evaluated with a complete blood cell count and liver function tests.
  13. 13. Clinical Presentation The physical examination may be normal in patients with HELLP syndrome. 1- right upper quadrant tenderness 90 % 2- Edema is not a useful marker 3- Hypertension and proteinuria may be absent or mild.
  14. 14. 90 65 30 31 0 10 20 30 40 50 60 70 80 90 symptoms general malase epigastric pain vomiting haedache Clinical Presentation SYMPTOMS
  15. 15. 90 30 30 0 10 20 30 40 50 60 70 80 90 signs Rt.hypochond.pain edema hypertention + proteinuria signs Clinical Presentation
  16. 16. Diagnosis Martin JN Jr, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG.  There is agreement among most of the authors that, the diagnosis requires the concurrence of hemolysis, elevated liver enzymes, and low platelet count. However, there is obviously still a lack of consensus on the laboratory parameters and their cutoff values used to diagnose
  17. 17. Laboratory Diagnostic Criteria for HELLP syndrome Haemolysis Abnormal peripheral smear : spherocytes, schistocytes, triangular cells and burr cells Total Bilirubin level > 1.2 mg/dL Lactate dehydrogenase level > 600U/L Elevated liver function test result Serum aspartate amino transferase level > 70U/L Lactate dehydrogenase level >600 U/L Low platelet count Platelet count < 150 000/mm3
  18. 18. Platelet count appears to be the most reliable indicator of the presence of HELLP syndrome
  19. 19. Clinical utility of strict diagnostic criteria for the HELLP the use of strict diagnostic criteria in the definition of the HELLP syndrome allows for greater prediction of complication rates. and define the cases that are Eligible to conservative management
  20. 20. Classification full HELLP syndrome partial HELLP syndrome based on the number of abnormalities Audibert F, Friedman SA, Frangieh AY, Sibai BM. Am J Obstet Gynecol 1996; 175:460-4. considered for delivery within 48 hours candidates for more conservative management
  21. 21. Classification on the basis of platelet count class I, less than 50,000 per mm3 class II, 50,000 to less than 100,000 per mm3 class III, 100,000 to 150,000 per mm3
  22. 22. Management Corticosteroids Magnesium sulphate Hypotensive drugs Blood products Delivery
  23. 23. The treatment approach should be based on the estimated gestational age and the condition of the mother and fetus. Prolongation of pregnancy, in theory, may be favourable for the foetus whereas it remains controversial whether maternal condition is further deteriorated by expectant management Visser W, Wallenburg HC. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 1995;102:111-7
  24. 24. hypertension is controlled at less than 160/110 mm hg, Oliguria responds to fluid management . Elevated liver function values are not associated with right upper quadrant or epigastric pain. Class II –III .(platelet count).>50000 Eligibility to conservative management
  25. 25. The Cochrane Library holds two protocols which when complete may summarize evidence to date on the use of corticosteroids for HELLP syndrome . and interventionist versus expectant management of severe pre- eclampsia before term.
  26. 26. The antenatal administration of dexamethasone (Decadron) in a high dosage of 10 mg intravenously every 12 hours has been shown to markedly improve the laboratory abnormalities associated with HELLP syndrome. Steroids given antenatally do not prevent the typical worsening of laboratory abnormalities after delivery. However, laboratory abnormalities resolve more quickly in patients who continue to receive steroids postpartum. Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JN Jr. Am J Obstet Gynecol 1994;171:1148-53.
  27. 27.  Corticosteroid therapy should be instituted in patients with HELLP syndrome who have a platelet count of less than 100,000 per mm3 .And should be continued until liver function abnormalities are resolving and the platelet count is greater than 100,000 per mm3 Magann EF, Perry KG Jr, Meydrech EF, Harris RL, Chauhan SP, Martin JN Jr. Am J Obstet Gynecol 1994;171:1154-8.
  28. 28. Intravenously administered dexamethasone appears to be more effective than intramuscularly adminstered betamethasone for the antepartum treatment of mothers with HELLP syndrome. (Am J Obstet Gynecol 2001;184:1332-9.).
  29. 29. Administration of glucocorticoids increases the use of regional anesthesia in women with antepartum HELLP syndrome who have thrombocytopenia. (Am J Obstet Gynecol 2002;186:475-9.).
  30. 30. Patients treated with dexamethasone exhibit longer time to delivery; This facilitates maternal transfer to a tertiary care center and postnatal maturity of fetal lungs (Am J Obstet Gynecol 2002;186:475-9.).
  31. 31. Patients with HELLP syndrome should be treated prophylactically with magnesium sulfate to prevent seizures, whether hypertension is present or not.
  32. 32. Antihypertensive therapy should be initiated if blood pressure is consistently greater than 160/110 mm hg despite the use of magnesium sulfate. The goal is to maintain diastolic blood pressure between 90 and 100 mm hg.
  33. 33. The most commonly used antihypertensive agent has been hydralazine Labetolol Nifedipine
  34. 34. Between 38 -93 % of patients with HELLP syndrome receive some form of blood product.  Patients with a platelet count greater than 40,000 per mm3 are unlikely to bleed.
  35. 35. Patients who undergo cesarean section should be transfused if their platelet count is less than 50,000 per mm3 , Prophylactic transfusion of platelets at delivery does not reduce the incidence of postpartum hemorrhage or hasten normalization of the platelet count. . Patients with DIC should be given fresh frozen plasma and packed red blood cells.
  36. 36. Pain relief with intravenous narcotics and local anesthesia is acceptable but certainly not optimal for pain control. Epidural anesthesia has been controversial but it is the technique of choice when it can be accomplished safely. Insertion of an epidural catheter is generally safe in patients with a platelet count greater than 100,000 per mm3.  General anesthesia can be used when regional anesthesia is considered unsafe. Portis R, Jacobs MA, Skerman JH, Skerman EB. HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) pathophysiology and anesthetic considerations. AANA J 1997;65:37-47.
  37. 37. Complications
  38. 38. Complications The mortality rate for women with HELLP syndrome is approximately 1.1 %  From 1 to 25 % of affected women develop serious complications such as DIC, placental abruption, adult respiratory distress syndrome, hepatorenal failure, pulmonary edema, subcapsular hematoma and hepatic rupture.  A significant percentage of patients receive blood products. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000-6.
  39. 39. Infant morbidity and mortality rates range from 10 to 60 %, depending on the severity of maternal disease.  Infants affected by HELLP syndrome are more likely to experience intrauterine growth retardation and respiratory distress syndrome. Dotsch J, Hohmann M, Kuhl PG. Neonatal morbidity and mortality associated with maternal haemolysis, elevated liver enzymes and low platelets syndrome. Eur J Pediatr 1997;156:389-91. Complications
  40. 40. 1.10% 25% 60% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% matern.mort. maternal complication fetal complication Complications
  41. 41. take home Once the diagnosis of HELLP syndrome has been established, the best markers to follow are the maternal lactate dehydrogenase level and the maternal platelet count
  42. 42. The laboratory abnormalities in HELLP syndrome typically worsen after delivery and then begin to resolve by three to four days postpartum. Martin JN Jr, Blake PG, Perry KG Jr, McCaul JF, Hess LW, Martin RW. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol 1991;164(6 pt 1):1500-9. take home
  43. 43. The incidence of hemorrhagic complications is higher when platelet counts are < 40,000 per mm3 take home
  44. 44. Patients with HELLP syndrome who complain of severe right upper quadrant pain, neck pain or shoulder pain should be considered for hepatic imaging regardless of the severity of the laboratory abnormalities, to assess for subcapsular haematoma or rupture take home
  45. 45. Patients with HELLP syndrome should be routinely treated with corticosteroids. take home

PREGNANCY RELATED PREECLAMPSIA ASSICIATED CRITICAL CONDITION

Views

Total views

80

On Slideshare

0

From embeds

0

Number of embeds

0

Actions

Downloads

7

Shares

0

Comments

0

Likes

0

×